Telesis Bio Stock

Telesis Bio Liabilities 2024

Telesis Bio Liabilities

40.87 M USD

Ticker

TBIO

ISIN

US1920031010

In 2024, Telesis Bio's total liabilities amounted to 40.87 M USD, a 17.46% difference from the 34.8 M USD total liabilities in the previous year.

Telesis Bio Aktienanalyse

What does Telesis Bio do?

Telesis Bio Inc. is a US company dedicated to the production of biological and herbal dietary supplements. The company was founded in 2014 by a group of scientists and entrepreneurs led by Dr. David Turok. Telesis Bio's core business is the extraction of natural compounds from plants and offering them in various formulations as dietary supplements. The company places great emphasis on innovative technologies and the highest product quality. Telesis Bio is based in Atlanta, Georgia, and is divided into several business segments, including the production of herbal extracts, CBD oils and capsules, as well as the development of novel dietary supplements for a variety of applications. One of Telesis Bio's most well-known products is the CBD oil "Pure CBD Spectrum," derived from hemp and used as a pain relief aid. The company also offers CBD capsules and balms known for their anti-inflammatory and soothing properties. CBD products are currently in high demand in the US, and the company has successfully positioned itself in this growing market segment. Another important product of Telesis Bio is herbal extracts. The company uses only the highest quality herbs and plants from organic cultivation to produce its extracts. The herbal extracts are offered in various forms such as capsules, tablets, or tinctures and can be used to support the immune system, improve digestion, or aid in sleep. The company is committed to continually improving its products through comprehensive research and development. Telesis Bio also has its own research department with leading scientists in the fields of botany and nutritional sciences. This research ensures that the company's products always adhere to the latest scientific findings and highest quality standards. Telesis Bio is also committed to minimizing its environmental impact through its business activities. The company uses only environmentally friendly packaging and faster shipping to minimize its carbon footprint. Overall, the company has earned a good reputation as a reliable provider of quality products thanks to its innovative products and research and development. Telesis Bio strives to improve the health and well-being of its customers through high-quality dietary supplements, all while utilizing natural resources and protecting the environment. Telesis Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Telesis Bio's Liabilities

Telesis Bio's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Telesis Bio's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Telesis Bio's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Telesis Bio's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Telesis Bio’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Telesis Bio stock

What is the level of liabilities of Telesis Bio this year?

Telesis Bio has a debt balance of 40.87 M USD this year.

What were the liabilities of Telesis Bio compared to the previous year?

The liabilities of Telesis Bio have increased by 17.46% increased compared to the previous year.

What are the consequences of high debt for investors of Telesis Bio?

High liabilities can pose a risk for investors of Telesis Bio, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Telesis Bio?

Low liabilities mean that Telesis Bio has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Telesis Bio affect the company?

An increase in liabilities of Telesis Bio can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Telesis Bio affect the company?

A decrease in the liabilities of Telesis Bio can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Telesis Bio?

Some factors that can influence the liabilities of Telesis Bio include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Telesis Bio so important for investors?

The liabilities of Telesis Bio are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Telesis Bio take to modify the liabilities?

To change its liabilities, Telesis Bio can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Telesis Bio pay?

Over the past 12 months, Telesis Bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Telesis Bio is expected to pay a dividend of 0 USD.

What is the dividend yield of Telesis Bio?

The current dividend yield of Telesis Bio is .

When does Telesis Bio pay dividends?

Telesis Bio pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Telesis Bio?

Telesis Bio paid dividends every year for the past 0 years.

What is the dividend of Telesis Bio?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Telesis Bio located?

Telesis Bio is assigned to the 'Health' sector.

Wann musste ich die Aktien von Telesis Bio kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Telesis Bio from 8/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/1/2024.

When did Telesis Bio pay the last dividend?

The last dividend was paid out on 8/1/2024.

What was the dividend of Telesis Bio in the year 2023?

In the year 2023, Telesis Bio distributed 0 USD as dividends.

In which currency does Telesis Bio pay out the dividend?

The dividends of Telesis Bio are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Telesis Bio

Our stock analysis for Telesis Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Telesis Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.